androstane-3,17-diol has been researched along with Acute Promyelocytic Leukemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Desnoyers, S; Jegham, H; Maltais, R; Poirier, D; Roy, J | 1 |
| DeRoy, P; Poirier, D; Roy, J; Thibeault, D | 1 |
| He, Q; Jiang, D | 1 |
3 other study(ies) available for androstane-3,17-diol and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
A novel aminosteroid of the 5α-androstane-3α,17β-diol family induces cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells.
Topics: Androstane-3,17-diol; Antineoplastic Agents; Apoptosis; Caspases; Cell Cycle Checkpoints; Cell Differentiation; Cell Survival; Dose-Response Relationship, Drug; G1 Phase Cell Cycle Checkpoints; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Microscopy, Fluorescence; Poly(ADP-ribose) Polymerases; Resting Phase, Cell Cycle; Time Factors | 2012 |
Chemical synthesis of 2beta-amino-5alpha-androstane-3alpha,17beta-diol N-derivatives and their antiproliferative effect on HL-60 human leukemia cells.
Topics: Androstane-3,17-diol; Cell Differentiation; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia, Promyelocytic, Acute; Molecular Conformation; Stereoisomerism; Steroids; Structure-Activity Relationship; Tumor Cells, Cultured | 2008 |
A novel aminosteroid is active for proliferation inhibition and differentiation induction of human acute myeloid leukemia HL-60 cells.
Topics: Androstane-3,17-diol; Antineoplastic Agents; Cell Differentiation; Cell Division; Growth Inhibitors; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute | 1999 |